Based on the evidence described above, we hypothesized that the modulation of the SDF-1/CXCR4 axis might be involved in the TMP-mediated inhibition of pathological angiogenesis and the alleviation of pulmonary fibrosis and anti-thrombosis effects. This evidence concerns the gene CXCR4 and pulmonary fibrosis.